Between a rock and a hard place? (Q36399414)

14 August 2017

1 reference

title

Between a rock and a hard place? (English)

1 reference

14 August 2017

Adrian Whitty

1

1 reference

PubMed ID

16484997

14 August 2017

Gnanasambandam Kumaravel

series ordinal

2

1 reference

14 August 2017

1 March 2006

1 reference

14 August 2017

Nature Chemical Biology

1 reference

14 August 2017

2

1 reference

14 August 2017

3

1 reference

14 August 2017

112-118

1 reference

https://scigraph.springernature.com/pub.10.1038/nchembio0306-112

14 August 2017

0 references

cites work

Integration of NMR and high-throughput screening

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

Antagonists of protein-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Inhibition of protein-protein association by small molecules: approaches and progress

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Emerging biologic drugs for the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

A hot spot of binding energy in a hormone-receptor interface

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Binding of small molecules to an adaptive protein-protein interface

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Implications of protein flexibility for drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Fragment-based lead discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Fragment-Based Drug Discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Discovering high-affinity ligands for proteins: SAR by NMR

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Discovering high-affinity ligands for proteins

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Site-directed ligand discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Small molecule cytokine mimetics

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Kinase inhibitors: not just for kinases anymore

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Small-molecule inhibition of TNF-alpha

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

NMR-based techniques in the hit identification and optimisation processes

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Discovery of a potent small molecule IL-2 inhibitor through fragment assembly

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Privileged molecules for protein binding identified from NMR-based screening

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

The evolving role of natural products in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Molecular properties that influence the oral bioavailability of drug candidates

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Target-oriented and diversity-oriented organic synthesis in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Natural product-like chemical space: search for chemical dissectors of macromolecular interactions

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Predicting protein druggability

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Druggability indices for protein targets derived from NMR-based screening data

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO0306-112

7 January 2021

Identifiers

DOI

10.1038/NCHEMBIO0306-112

1 reference

PubMed ID

16484997

Dimensions Publication ID

14 August 2017

0 references

1 reference

PubMed ID

16484997